Communiqués Biofrontera Inc.

Actions

BFRI

US09077D2099

Marché Fermé - Nasdaq Autres places de cotation 21:56:54 15/07/2024			Varia. 5j.	Varia. 1 janv.
1,07 ^USD	+1,42 %		+24,27 %	-61,37 %

24/06	Biofrontera annonce le lancement d'une nouvelle source de lumière rouge approuvée par la FDA, la lampe RhodoLED® XL	CI
16/05	Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	24/06	AQ
Biofrontera : Certificate of Incorporation/Bylaws - Form 8-K	02/05	PU
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	21/02	AQ
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	21/02	AQ
Biofrontera : Notes to the Consolidated Financial Statements - Form 8-K	03/10/23	PU
SciBase strengthens US team with experienced Dermatology executive	04/09/23	AQ
BIOFRONTERA INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	02/06/23	AQ
Biofrontera : Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz®-PDT - Form 8-K	01/06/23	PU
BIOFRONTERA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	01/06/23	AQ
Biofrontera : Names Founder and Executive Chairman Hermann Luebbert as Chief Executive Officer - Form 8-K	30/05/23	PU
BIOFRONTERA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	30/05/23	AQ
Biofrontera : Failure to Satisfy Listing Rule - Form 8-K	27/05/23	PU
BIOFRONTERA INC. : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	12/05/23	AQ
BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)	28/04/23	AQ
BIOFRONTERA INC. : Entry into a Material Definitive Agreement (form 8-K)	17/04/23	AQ
BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	13/03/23	AQ
BIOFRONTERA INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	08/03/23	AQ
BIOFRONTERA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	02/03/23	AQ
BIOFRONTERA INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	09/01/23	AQ
Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of Stockholders	16/12/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Biofrontera Inc.

Actions

BFRI

US09077D2099

Communiqués

Filtres